Lucy Potter
Department of General Internal Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Instructor, Department of General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2020 | University of Texas, Houston, TX, USA, MPH, Public health |
| 2017 | Baylor College of Medicine, Houston, TX, USA, MD, Medicine |
| 2012 | Rice University, Houston, TX, USA, BA, Science |
Postgraduate Training
| 2020-2023 | Clinical Residency, Internal Medicine, University of Nevada-Reno, Reno, NV |
Honors & Awards
| 2020 | Delta Omega Honorary Society of Public Health |
| 2019 | Best in Congress Poster Award, American Transplant Congress |
| 2012 | Clark P. Read Award for Excellence in Ecology & Evolutionary Biology |
| 2012 | Magna cum laude |
| 2012 | Phi Beta Kappa Honor Society |
| 2008 | Rice-Baylor Baccalaureate-MD Medical Scholar |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Tariq N, Saharia A, Nwokedi U, Hobeika MJ, Mobley CM, Hsu D, Potter LM, Moore LW, Elaileh A, Sherman V, Ghobrial RM. Combined liver transplantation and sleeve gastrectomy: Report of a brief-interval staged approach. Liver Transpl 29(4):422-430, 2023. e-Pub 2022. PMID: 35976078.
- Saharia A, Potter L, Baio F, Elshawwaf M, Abdelrahim M, Heyne K. Commentary on Neoadjuvant Versus Surgery First Approach in Resectable Pancreatic Ductal Adenocarcinoma. Am J Clin Oncol 43(10):753-754, 2020. PMID: 32969854.
- Saharia A, Potter LM, Baio F, Elaileh A, Mobley C, Ghobrial RM, Abdelrahim M, Heyne K.. Is Surgery-first Still a Reasonable Option in the Era of Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer?. AM. J Clini Oncol 43(4):298-304, 2020.
- Ahmed Elaileh, Ashish Saharia, Lucy Potter , Flavio Baio, Afnan Ghafel, Maen Abdelrahim, Kirk Heyne. Promising new treatments for pancreatic cancer in the era of targeted and immune therapies. AM. J Cancer Research 9(9), 2019. PMID: 31598392.
Other Articles
- Saharia A, Potter LM, Baio F, Elaileh A, Mobley C, Ghobrial RM, Abdelrahim M, Heyne K Is surgery-first still a reasonable option in the era of neoadjuvant chemotherapy for resectable pancreatic cancer. AM.J Clin Oncol 43(4):298-304, 2020.
Patient Reviews
CV information above last modified March 15, 2024